148 related articles for article (PubMed ID: 17475214)
1. PI3K is negatively regulated by PIK3IP1, a novel p110 interacting protein.
Zhu Z; He X; Johnson C; Stoops J; Eaker AE; Stoffer DS; Bell A; Zarnegar R; DeFrances MC
Biochem Biophys Res Commun; 2007 Jun; 358(1):66-72. PubMed ID: 17475214
[TBL] [Abstract][Full Text] [Related]
2. PIK3IP1, a negative regulator of PI3K, suppresses the development of hepatocellular carcinoma.
He X; Zhu Z; Johnson C; Stoops J; Eaker AE; Bowen W; DeFrances MC
Cancer Res; 2008 Jul; 68(14):5591-8. PubMed ID: 18632611
[TBL] [Abstract][Full Text] [Related]
3. Pik3ip1 modulates cardiac hypertrophy by inhibiting PI3K pathway.
Song HK; Kim J; Lee JS; Nho KJ; Jeong HC; Kim J; Ahn Y; Park WJ; Kim DH
PLoS One; 2015; 10(3):e0122251. PubMed ID: 25826393
[TBL] [Abstract][Full Text] [Related]
4. Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers.
Geering B; Cutillas PR; Nock G; Gharbi SI; Vanhaesebroeck B
Proc Natl Acad Sci U S A; 2007 May; 104(19):7809-14. PubMed ID: 17470792
[TBL] [Abstract][Full Text] [Related]
5. Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits?
Geering B; Cutillas PR; Vanhaesebroeck B
Biochem Soc Trans; 2007 Apr; 35(Pt 2):199-203. PubMed ID: 17371237
[TBL] [Abstract][Full Text] [Related]
6. [Both PIK3IP1 and its novel found splicing isoform, PIK3IP1-v1, are located on cell membrane and induce cell apoptosis].
Gao P; Zeng WT; Deng WW; Li N; Shi TP; Ma DL
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 40(6):572-7. PubMed ID: 19088825
[TBL] [Abstract][Full Text] [Related]
7. Roles of G beta gamma in membrane recruitment and activation of p110 gamma/p101 phosphoinositide 3-kinase gamma.
Brock C; Schaefer M; Reusch HP; Czupalla C; Michalke M; Spicher K; Schultz G; Nürnberg B
J Cell Biol; 2003 Jan; 160(1):89-99. PubMed ID: 12507995
[TBL] [Abstract][Full Text] [Related]
8. Class IA PI3K regulatory subunits: p110-independent roles and structures.
Fox M; Mott HR; Owen D
Biochem Soc Trans; 2020 Aug; 48(4):1397-1417. PubMed ID: 32677674
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of p85αPI3KSer83 phosphorylation prevents cell proliferation and invasion in prostate cancer cells.
Feola A; Cimini A; Migliucci F; Iorio R; Zuchegna C; Rothenberger R; Cito L; Porcellini A; Unteregger G; Tombolini V; Giordano A; Di Domenico M
J Cell Biochem; 2013 Sep; 114(9):2114-9. PubMed ID: 23553770
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of the autophosphorylation sites of phosphoinositide 3-kinase isoforms beta and gamma.
Czupalla C; Culo M; Müller EC; Brock C; Reusch HP; Spicher K; Krause E; Nürnberg B
J Biol Chem; 2003 Mar; 278(13):11536-45. PubMed ID: 12502714
[TBL] [Abstract][Full Text] [Related]
11. Galpha16 interacts with Class IA phosphatidylinositol 3-kinases and inhibits Akt signaling.
Yeung WW; Wong YH
Cell Signal; 2010 Sep; 22(9):1379-87. PubMed ID: 20471473
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the retinal insulin receptor beta-subunit with the p85 subunit of phosphoinositide 3-kinase.
Rajala RV; McClellan ME; Chan MD; Tsiokas L; Anderson RE
Biochemistry; 2004 May; 43(19):5637-50. PubMed ID: 15134438
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the inter-SH2 domain of the regulatory subunit of phosphoinositide 3-kinase: effects on catalytic subunit binding and holoenzyme function.
Elis W; Lessmann E; Oelgeschlager M; Huber M
Biol Chem; 2006 Dec; 387(12):1567-73. PubMed ID: 17132102
[TBL] [Abstract][Full Text] [Related]
14. The negative regulation of phosphoinositide 3-kinase signaling by p85 and it's implication in cancer.
Luo J; Cantley LC
Cell Cycle; 2005 Oct; 4(10):1309-12. PubMed ID: 16131837
[TBL] [Abstract][Full Text] [Related]
15. Isoform-specific activities of the regulatory subunits of phosphatidylinositol 3-kinases - potentially novel therapeutic targets.
Ito Y; Hart JR; Vogt PK
Expert Opin Ther Targets; 2018 Oct; 22(10):869-877. PubMed ID: 30205700
[TBL] [Abstract][Full Text] [Related]
16. Cellular retinol-binding protein-I inhibits PI3K/Akt signaling through a retinoic acid receptor-dependent mechanism that regulates p85-p110 heterodimerization.
Farias EF; Marzan C; Mira-y-Lopez R
Oncogene; 2005 Feb; 24(9):1598-606. PubMed ID: 15608670
[TBL] [Abstract][Full Text] [Related]
17. The Unique Non-Catalytic C-Terminus of P37delta-PI3K Adds Proliferative Properties In Vitro and In Vivo.
Ejeskär K; Vickes O; Kuchipudi A; Wettergren Y; Uv A; Rotter Sopasakis V
PLoS One; 2015; 10(5):e0127497. PubMed ID: 26024481
[TBL] [Abstract][Full Text] [Related]
18. Conjugation of SUMO to p85 leads to a novel mechanism of PI3K regulation.
de la Cruz-Herrera CF; Baz-Martínez M; Lang V; El Motiam A; Barbazán J; Couceiro R; Abal M; Vidal A; Esteban M; Muñoz-Fontela C; Nieto A; Rodríguez MS; Collado M; Rivas C
Oncogene; 2016 Jun; 35(22):2873-80. PubMed ID: 26411363
[TBL] [Abstract][Full Text] [Related]
19. Class I phosphoinositide 3-kinase (PI3K) regulatory subunits and their roles in signaling and disease.
Rathinaswamy MK; Burke JE
Adv Biol Regul; 2020 Jan; 75():100657. PubMed ID: 31611073
[TBL] [Abstract][Full Text] [Related]
20. p37δ is a new isoform of PI3K p110δ that increases cell proliferation and is overexpressed in tumors.
Fransson S; Uv A; Eriksson H; Andersson MK; Wettergren Y; Bergo M; Ejeskär K
Oncogene; 2012 Jul; 31(27):3277-86. PubMed ID: 22020336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
